Literature DB >> 25763509

Bladder and Bowel Dysfunction Is Common in Both Men and Women with Mutation of the ABCD1 Gene for X-Linked Adrenoleukodystrophy.

Johann Hofereiter1, Matthew D Smith, Jai Seth, Katarina Ivana Tudor, Zoe Fox, Anton Emmanuel, Elaine Murphy, Robin H Lachmann, Jalesh Panicker.   

Abstract

BACKGROUND: X-linked adrenoleukodystrophy (X-ALD) is a disorder caused by mutations in the ABCD1 gene. The commonest phenotype of X-ALD is adrenomyeloneuropathy (AMN), which is characterised by involvement of the spinal cord and peripheral nerves. The aim of this study was to evaluate bladder and bowel symptoms in men with AMN and female X-ALD carriers.
METHODS: In this cross-sectional study, patients with confirmed mutation of the ABCD1 gene attending a tertiary care service were approached about bladder and bowel complaints and completed the Urinary Symptom Profile (USP), Qualiveen Short Form (SF-Qualiveen), International Prostate Symptom Score (IPSS) and Neurogenic Bowel Dysfunction (NBD) questionnaires. Neurological disability was assessed using the Expanded Disability Status Scale (EDSS).
RESULTS: Forty-eight patients participated, 19 males (mean EDSS score (n = 16) 5.0 (95% CI ± 1.03)) and 29 females (mean EDSS score (n = 25) 3.2 (95% CI ± 0.98)). Overactive bladder (OAB) symptoms were reported in both males (100%, n = 19) and females (86.2%, n = 25). There was no significant gender difference in severity of OAB symptoms (P = 0.35) and impact on quality of life (P = 0.13). Furthermore, there was no significant difference in OAB severity when symptoms were compared between female carriers and a cohort of women (n = 17) with spinal cord damage due to multiple sclerosis (P = 0.27). Twenty-one percent (n = 4) of males and 10% (n = 3) of females had moderate to severe bowel dysfunction.
CONCLUSIONS: Bladder and bowel complaints are common in both men with AMN and female carriers. They have a significant impact on the quality of life yet are under-reported and under-treated. Though having an X-linked pattern of inheritance, female carriers may experience overactive bladder symptoms which are as severe as in male patients and are likely to be neurological in origin.

Entities:  

Year:  2015        PMID: 25763509      PMCID: PMC4486267          DOI: 10.1007/8904_2015_414

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  31 in total

Review 1.  The bare essentials: uro-neurology.

Authors:  Jalesh N Panicker; Clare J Fowler
Journal:  Pract Neurol       Date:  2010-06

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.

Authors:  Marc Engelen; Mathieu Barbier; Inge M E Dijkstra; Remmelt Schür; Rob M A de Bie; Camiel Verhamme; Marcel G W Dijkgraaf; Patrick A Aubourg; Ronald J A Wanders; Bjorn M van Geel; Marianne de Visser; Bwee T Poll-The; Stephan Kemp
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

4.  Nerve conduction studies in adrenomyeloneuropathy.

Authors:  V Chaudhry; H W Moser; D R Cornblath
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

5.  Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.

Authors:  B P O'Neill; H W Moser; K M Saxena; L C Marmion
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

6.  Voiding dysfunction in x-linked adrenoleukodystrophy: symptom score and urodynamic findings.

Authors:  M Silveri; M De Gennaro; C Gatti; C Bizzarri; G Mosiello; M Cappa
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

7.  The adrenoleukomyeloneuropathy complex: expression in four generations.

Authors:  B P O'Neill; L C Marmion; E R Feringa
Journal:  Neurology       Date:  1981-02       Impact factor: 9.910

Review 8.  A UK consensus on the management of the bladder in multiple sclerosis.

Authors:  C J Fowler; J N Panicker; M Drake; C Harris; S C W Harrison; M Kirby; M Lucas; N Macleod; J Mangnall; A North; B Porter; S Reid; N Russell; K Watkiss; M Wells
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

9.  X-linked adrenoleukodystrophy in heterozygous female patients: women are not just carriers.

Authors:  Charles Marques Lourenço; Gustavo Novelino Simão; Antonio Carlos Santos; Wilson Marques
Journal:  Arq Neuropsiquiatr       Date:  2012-07       Impact factor: 1.420

10.  [A case of adrenomyeloneuropathy with marked spinal cord atrophy on magnetic resonance imaging].

Authors:  H Tezuka; Y Tachibana; A Terashi
Journal:  Rinsho Shinkeigaku       Date:  1991-04
View more
  3 in total

1.  Beyond gait and balance: urinary and bowel dysfunction in X-linked adrenoleukodystrophy.

Authors:  Camille S Corre; Natalie Grant; Reza Sadjadi; Douglas Hayden; Catherine Becker; Pablo Gomery; Florian S Eichler
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

Review 2.  ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy.

Authors:  Alyssa M Volmrich; Lauren M Cuénant; Irman Forghani; Sharon L Hsieh; Lauren T Shapiro
Journal:  Appl Clin Genet       Date:  2022-08-12

3.  Impaired plasticity of macrophages in X-linked adrenoleukodystrophy.

Authors:  Isabelle Weinhofer; Bettina Zierfuss; Simon Hametner; Magdalena Wagner; Niko Popitsch; Christian Machacek; Barbara Bartolini; Gerhard Zlabinger; Anna Ohradanova-Repic; Hannes Stockinger; Wolfgang Köhler; Romana Höftberger; Günther Regelsberger; Sonja Forss-Petter; Hans Lassmann; Johannes Berger
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.